Chicago—A recently concluded study has failed to show differences in treatment options that would reduce US mortality rates for patients who receive hemodialysis.
The results from the Hemodialysis (HEMO) Study showed that mortality rates were basically the same for patients regardless of combinations of standard or high doses of hemodialysis and low and high dialysis membrane flux. The study results were presented at the National Kidney Foundation's (NKF) Clinical Nephrology Meetings by lead investigator Garabed Eknoyan, MD, a professor of medicine at Baylor College of Medicine in Houston.
Mitka M. How to Reduce Mortality in Hemodialysis Patients Still a Puzzle. JAMA. 2002;287(20):2643-2644. doi:10.1001/jama.287.20.2643-JMN0522-3-1